Medicines Co. (MDCO) reported fourth quarter non-GAAP net income of $0.78 per share Wednesday morning, which topped the consensus estimate of $0.21. Net revenue increased by 20.6 percent to $159.5 million, from $132.2 million in the year-ago quarter. The consensus estimate was for revenues of $136.46 million.
Medicines Co. gapped up slightly Wednesday and advanced further around the middle of the afternoon. Shares finished up by 1.42 at $32.57 on above average volume. The stock broke out of a 1-month range and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.